A blinded evaluation of MYCIN's advice
Eight independent specialists, not knowing the authorship, rated MYCIN's prescriptions for meningitis above those of five university physicians.
Why it matters
The first blinded comparison of a machine with experts in a practical domain, and the machine did not lose.
Ten meningitis cases were assessed; MYCIN's recommendations were rated acceptable 65 percent of the time against 42.5 to 62.5 percent for the faculty. The system never failed to cover a pathogen that needed covering. MYCIN still did not reach the clinic: liability questions, no integration with hospital systems and the need to enter data by hand all stood in the way.